CLEVIPREX single-use, ready-to-use vials

Maximum dose1

  • Most patients treated with maximum doses of 16 mg/h (32 mL/h) or less
  • There is limited short-term experience with doses as high as 32 mg/h (64 mL/h)
  • Because of lipid load restrictions, no more than 1000 mL or an average of 21 mg/h (42 mL/h) of CLEVIPREX infusion is recommended per 24-hour period
  • There is little experience with infusion durations beyond 72 hours at any dose